Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple ...

The Patient-Centered Outcomes Research Institute (PCORI) gave the Cleveland Clinic $6.7 million to identify optimal RRMS ...

Dr. Jon LaPook reports on new clinical trial findings that suggest some cancer patients could bypass chemotherapy, radiation, ...

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis (MS).

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...